BCAC media release, 15 January 2020: Breast Cancer Aotearoa Coalition (BCAC) is delighted to hear that Ibrance (palbociclib) will be funded by PHARMAC from 1 April 2020.
BCAC would love you to show support for an intrepid couple who are cycling from Dunedin to Parliament to garner support for a petition that would help improve the lives of women with breast cancer and people with other diseases.
Advocates are always a big part of the San Antonio Breast Cancer Symposium, with wonderful opportunities to share ideas, experience, priorities and plans. This photo shows patient advocates together in Texas. The photo is courtesy of the Alamo Breast Cancer Foundation, which we are very pleased sponsored our Deputy Chair Emma Crowley to attend the Symposium. Emma is pictured in the back row in a white Nike T-shirt.
Videos for advocates
The San Antonio Breast Cancer Symposium (SABCS) is underway in Texas. BCAC has two delegates attending – Deputy Chair Emma Crowley and Secretary Fay Sowerby. They are there to learn the latest developments in breast cancer treatment and research to bring back home to help BCAC support and inform women with breast cancer.
- Moderated at the San Antonio Breast Cancer Symposium by Mathew Ellis from Baylor College
- Reported on here by BCAC Secretary Fay Sowerby
Initial trial results on the cost and effectiveness of MRI breast cancer screening compared to mammography, in women with a familial risk, have been presented at the San Antonio Breast Cancer Symposium. The FaMRIsc study is the first randomised trial that has made this comparison.
By Shoshana Maasland, Te Waha Nui (AUT University). Photo also by Shoshana
Fay Sowerby was already involved in breast cancer research when she was diagnosed with the illness.
The secretary of Breast Cancer Aotearoa Coalition was well-informed and had been having annual mammograms and occasional ultrasounds. She had recently received an all-clear letter advising she wouldn’t need another mammogram for two years.
Four months later, though, she felt a lump.
Funding for new medicines | produced an updated Step by Step support pack | continued our wide-ranging work to ensure world-class detection, treatment and care for women with breast cancer
BCAC media release, 5 December 2019
Breast Cancer Aotearoa Coalition (BCAC) is delighted to learn that fulvestrant (Faslodex) will be funded by PHARMAC in the New Year, BCAC Chair Libby Burgess says.
We are very grateful to LeRêve (NZ), a direct selling company, for taking part in an Australasian fun run to raise money for BCAC. Forty-five LeRêve (NZ) consultants, staff, friends and family travelled to the Gold Coast to run or walk 5km in the event with their Australian counterparts.